OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Enhancing these processes involves modifying various factors, including cell line selection, media composition, and bioreactor conditions. A key goal is to increase antibody titer while lowering production expenses a